Icon PLC (ICLR)
291.82
-0.20
(-0.07%)
USD |
NASDAQ |
Apr 18, 16:00
291.73
-0.09
(-0.03%)
After-Hours: 20:00
Icon Enterprise Value: 27.47B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 18, 2024 | 27.47B |
April 17, 2024 | 27.49B |
April 16, 2024 | 27.65B |
April 15, 2024 | 28.07B |
April 12, 2024 | 28.64B |
April 11, 2024 | 29.17B |
April 10, 2024 | 29.18B |
April 09, 2024 | 29.72B |
April 08, 2024 | 29.87B |
April 05, 2024 | 29.70B |
April 04, 2024 | 29.23B |
April 03, 2024 | 29.88B |
April 02, 2024 | 30.01B |
April 01, 2024 | 30.76B |
March 28, 2024 | 31.11B |
March 27, 2024 | 30.58B |
March 26, 2024 | 30.61B |
March 25, 2024 | 30.60B |
March 22, 2024 | 30.78B |
March 21, 2024 | 31.22B |
March 20, 2024 | 31.09B |
March 19, 2024 | 31.01B |
March 18, 2024 | 30.83B |
March 15, 2024 | 31.01B |
March 14, 2024 | 30.92B |
Date | Value |
---|---|
March 13, 2024 | 30.91B |
March 12, 2024 | 31.31B |
March 11, 2024 | 30.82B |
March 08, 2024 | 31.00B |
March 07, 2024 | 31.44B |
March 06, 2024 | 31.08B |
March 05, 2024 | 31.07B |
March 04, 2024 | 30.72B |
March 01, 2024 | 30.25B |
February 29, 2024 | 29.85B |
February 28, 2024 | 30.08B |
February 27, 2024 | 30.00B |
February 26, 2024 | 29.69B |
February 23, 2024 | 29.31B |
February 22, 2024 | 29.25B |
February 21, 2024 | 26.88B |
February 20, 2024 | 26.78B |
February 16, 2024 | 27.24B |
February 15, 2024 | 27.33B |
February 14, 2024 | 27.54B |
February 13, 2024 | 26.09B |
February 12, 2024 | 26.33B |
February 09, 2024 | 26.37B |
February 08, 2024 | 25.99B |
February 07, 2024 | 25.59B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.997B
Minimum
Mar 19 2020
31.44B
Maximum
Mar 07 2024
17.17B
Average
19.92B
Median
Enterprise Value Benchmarks
Fonar Corp | 47.49M |
XWELL Inc | -9.224M |
ProPhase Labs Inc | 103.69M |
Applied DNA Sciences Inc | 2.269M |
Veracyte Inc | 1.225B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 216.42M |
Revenue (Quarterly) | 2.066B |
Total Expenses (Quarterly) | 1.791B |
EPS Diluted (Quarterly) | 2.60 |
Gross Profit Margin (Quarterly) | 30.03% |
Profit Margin (Quarterly) | 10.47% |
Earnings Yield | 2.53% |
Operating Earnings Yield | 4.33% |
Normalized Earnings Yield | 2.863 |